RGEN

#1098
Repligen Corporation - Common Stock
124.9 1 USD
+1.78%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
1.24
125.20
년간 변동
1.12
175.57
일일 변동
+1.78%
월간 변동
+9.49%
6달 변화
-25.90%
년간 변동율
-24.61%
이전 종가
122.7 3
Open
1.2 5
저가
1.2 4
High
125.2 0
양
122
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 7.05 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry 의료기기 & 의료용 소모품
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
190.53
주가매출액비율
0.01

Repligen Corporation - Common Stock

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

뉴스